New hormonal therapy for advanced breast cancer called Femara (Fe-MAR-a, letrozole)
September 1997
You'll see a new hormonal therapy for advanced breast cancer called Femara (Fe-MAR-a, letrozole).
Novartis is launching it now in both the U.S. and Canada.
Femara is for postmenopausal women whose cancer progresses... despite treatment with an antiestrogen such as tamoxifen (Nolvadex).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote